首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Structural basis for the specific inhibition of protein kinase G, a virulence factor of Mycobacterium tuberculosis
【24h】

Structural basis for the specific inhibition of protein kinase G, a virulence factor of Mycobacterium tuberculosis

机译:特异性抑制结核分枝杆菌毒力因子蛋白激酶G的结构基础

获取原文
获取原文并翻译 | 示例
           

摘要

The pathogenicity of mycobacteria such as Mycobacterium tuberculosis is closely associated with their capacity to survive within host macrophages. A crucial virulence factor for intracellular mycobacterial rnsurvival is protein kinase G (PknG), a eukaryotic-like serine/threonine protein kinase expressed by pathogenic mycobacteria that blocks the intracellular degradation of mycobacteria in lysosomes. Inhibition of PknG with the highly selective low-molecular-weight inhibitor AX20017 results in mycobacterial transfer to lysosomes and killing of the mycobacteria. Here, we report the 2.4 A x-ray crystal structure of PknG in complex with AX20017. The unique multidomain topology of PknG reveals a central kinase domain that is flanked by N- and C-terminal rubredoxin and tetratrico-peptide repeat domains, respectively. Directed mutagenesis rnsuggests that the rubredoxin domain functions as a regulator of PknG kinase activity. The structure of PknG-AX20017 further reveals that the inhibitor is buried deep within the adenosine-binding site, targeting an active conformation of the kinase domain. Remarkably, although the topology of the kinase domain is reminiscent of eukaryotic kinases, the AX20017-binding pocket is shaped by a unique set of amino acid side chains that are not found in any human kinase. Directed mutagenesis of the unique set of residues resulted in a drastic loss of the compound's inhibitory potency. Our results explain the specific mode of action of AX20017 and demonstrate that virulence factors highly homologous to host molecules can be successfully targeted to block the proliferation of M. tuberculosis.
机译:结核分枝杆菌等分枝杆菌的致病性与其在宿主巨噬细胞中存活的能力密切相关。细胞内分枝杆菌存活的关键毒力因子是蛋白激酶G(PknG),蛋白激酶G是由致病性分枝杆菌表达的真核样丝氨酸/苏氨酸蛋白激酶,可阻止溶酶体中分枝杆菌的细胞内降解。用高度选择性的低分子量抑制剂AX20017抑制PknG会导致分枝杆菌转移到溶酶体并杀死分枝杆菌。在这里,我们报告了与AX20017配合使用的PknG的2.4 A X射线晶体结构。 PknG独特的多域拓扑结构揭示了一个中央激酶结构域,其侧翼分别是N和C末端的氧化还原酶和四肽重复结构域。定向诱变表明,rubredoxin域起着PknG激酶活性调节剂的作用。 PknG-AX20017的结构进一步揭示,该抑制剂被埋在腺苷结合位点深处,靶向激酶结构域的活性构象。值得注意的是,尽管激酶结构域的拓扑结构使人联想到真核激酶,但AX20017结合口袋的形状却是在任何人类激酶中都找不到的独特的氨基酸侧链集。独特的一组残基的定向诱变导致该化合物的抑制能力急剧下降。我们的结果解释了AX20017的特定作用方式,并证明与宿主分子高度同源的毒力因子可以成功地靶向阻断结核分枝杆菌的增殖。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号